CClinicalTrials.gg
CompletedNCT05712811Updated Feb 6, 2023

Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts

An interventional study of CRYOTHERAPY and Tricholoracetic acid in Warts, sponsored by Combined Military Hospital Abbottabad. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-06.

Sponsored by Combined Military Hospital Abbottabad · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jun 2022, registered Jan 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Objective: To compare the efficacy of cryotherapy using liquid nitrogen (cryoget method) versus trichloroacetic acid 90% (applicator method) in treatment of common warts.

Study Design: Randomized Control Trial. Place And Duration of Study: Department of Dermatology, CMH Abbottabad from Jun 2022 to Nov, 2022.

Read the detailed description

A total of 60 patients were enrolled in this investigation by non-probability consecutive sampling technique. Sample size was calculated using WHO sample size calculator and patients were randomized into two equal groups, A and B, each comprising of 30 patients through lottery method. Patients with common warts such as hard lesions, raised lumps with rough surfaces at the back of their fingers, around nails and palm of their hands between the ages of 18 and 60 were included, whereas those with genital warts, cardiac, hepatic, renal, or hypercholesterolemia were excluded.

02

Conditions studied

  • Warts

Browse trials for

03

In context

Warts

180 studies on the registry are indexed under Warts; 28 are open to participants now.

This study's enrollment of 60 is below the median of 70 across 159 interventional studies indexed under Warts.

Browse Warts studies →

Lead sponsor

Combined Military Hospital Abbottabad is the lead sponsor of 24 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patient presented with common warts in dermatology opd

Exclusion criteria

Exclusion Criteria:

    • Patients with warts on toes and tip of fingers

      • genital warts
      • cardiac, hepatic and renal disease
      • hypercholesterolemia
      • hypersensitivity reactions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Group A cryotherapy

    Cryotherapy Group A had their warts treated once every two weeks for a total of twelve weeks, with liquid nitrogen using cryoget method for 10 to 15 seconds on each lesion (depending on size, until a narrow white rim of around 1 mm developed around it).

    Drug: CRYOTHERAPY

  • Active comparator
    Group B Topical TCA 90%

    Topical TCA 90 % Warts in Group B were treated with liquid TCA 90% by an applicator every two weeks for a total of twelve weeks. After 20 minutes, patients were instructed to remove the solution by washing their warts with water or regular saline

    Drug: Tricholoracetic acid

Interventions

  • DrugCRYOTHERAPY

    Group A had their warts treated once every two weeks for a total of twelve weeks, with liquid nitrogen using cryoget method for 10 to 15 seconds on each lesion (depending on size, until a narrow white rim of around 1 mm developed around it).

    Also known as: Liquid nitrogen

  • DrugTricholoracetic acid

    Group B were treated with liquid TCA 90% by an applicator every two weeks for a total of twelve weeks. After 20 minutes, patients were instructed to remove the solution by washing their warts with water or regular saline.

    Also known as: Peeling agent

06

What researchers measure

Primary outcomes

  1. Comparison of cryotherapy and Tricholoracetic acid 90% in treatment of common warts

    Outcome was determined at the end of third month and the patients were labelled as cured and the efficacy was labelled as "Yes" in cases with absence of all the lesions. After twelve weeks of therapy, individuals with persistent warts were regarded as cases of treatment failure and efficacy was labelled as "No".

    Time frame: 12 weeks

07

Study locations

1 site
  • Cmh abbottabad
    Abbottābād, Kpk 22010, Pakistan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05712811
Lead sponsor
Combined Military Hospital Abbottabad
Responsible party
Dr kiran gul (Principal investigator, Combined Military Hospital Abbottabad) — Principal investigator
First posted
Feb 6, 2023
Start date
Jun 1, 2022
Primary completion
Nov 30, 2022
Completion
Nov 30, 2022
Last update
Feb 6, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion